Treatment preferences and values of physician and general patients with AML population, as stratified by HCT and non-HCT recipients
| . | . | All patients at enrollment . | Non-HCT at 3- or 6-mo follow-up time point∗ . | HCT at closest time point before transplant . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | . | Rank of importance, n (%) . | Rank of importance, n (%) . | Rank of importance, n (%) . | ||||||
| Patient survey | Objective | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| Cure | 430 (80) | 57 (11) | 52 (10) | 134 (74) | 29 (16) | 17 (9) | 201 (87) | 19 (8) | 10 (4) | |
| QOL | 188 (36) | 217 (41) | 123 (23) | 90 (51) | 55 (31) | 32 (18) | 99 (44) | 85 (38) | 40 (18) | |
| LOL | 173 (33) | 143 (27) | 207 (40) | 56 (32) | 56 (32) | 65 (36) | 84 (38) | 59 (26) | 81 (36) | |
| . | . | All patients at enrollment . | Non-HCT at 3- or 6-mo follow-up time point∗ . | HCT at closest time point before transplant . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | . | Rank of importance, n (%) . | Rank of importance, n (%) . | Rank of importance, n (%) . | ||||||
| Patient survey | Objective | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| Cure | 430 (80) | 57 (11) | 52 (10) | 134 (74) | 29 (16) | 17 (9) | 201 (87) | 19 (8) | 10 (4) | |
| QOL | 188 (36) | 217 (41) | 123 (23) | 90 (51) | 55 (31) | 32 (18) | 99 (44) | 85 (38) | 40 (18) | |
| LOL | 173 (33) | 143 (27) | 207 (40) | 56 (32) | 56 (32) | 65 (36) | 84 (38) | 59 (26) | 81 (36) | |
| . | . | More important objective, n (%) . | More important objective, n (%) . | More important objective, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient survey . | Cure vs QOL . | Cure . | Equal . | QOL . | Cure . | Equal . | QOL . | Cure . | Equal . | QOL . |
| 313 (60) | 130 (25) | 80 (15) | 81 (47) | 52 (30) | 40 (23) | 121 (54) | 82 (37) | 21 (9) | ||
| . | . | More important objective, n (%) . | More important objective, n (%) . | More important objective, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient survey . | Cure vs QOL . | Cure . | Equal . | QOL . | Cure . | Equal . | QOL . | Cure . | Equal . | QOL . |
| 313 (60) | 130 (25) | 80 (15) | 81 (47) | 52 (30) | 40 (23) | 121 (54) | 82 (37) | 21 (9) | ||
| . | . | More important objective, n (%) . | More important objective, n (%) . | More important objective, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient survey . | Cure vs LOL . | Cure . | Equal . | LOL . | Cure . | Equal . | LOL . | Cure . | Equal . | LOL . |
| 318 (61) | 129 (25) | 73 (14) | 101 (58) | 50 (29) | 22 (13) | 130 (58) | 79 (35) | 15 (7) | ||
| . | . | More important objective, n (%) . | More important objective, n (%) . | More important objective, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient survey . | Cure vs LOL . | Cure . | Equal . | LOL . | Cure . | Equal . | LOL . | Cure . | Equal . | LOL . |
| 318 (61) | 129 (25) | 73 (14) | 101 (58) | 50 (29) | 22 (13) | 130 (58) | 79 (35) | 15 (7) | ||
| . | . | More important objective, n (%) . | More important objective, n (%) . | More important objective, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient survey . | QOL vs LOL . | QOL . | Equal . | LOL . | QOL . | Equal . | LOL . | QOL . | Equal . | LOL . |
| 240 (46) | 132 (25) | 149 (29) | 90 (51) | 49 (28) | 36 (21) | 94 (42) | 82 (37) | 46 (21) | ||
| . | . | More important objective, n (%) . | More important objective, n (%) . | More important objective, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient survey . | QOL vs LOL . | QOL . | Equal . | LOL . | QOL . | Equal . | LOL . | QOL . | Equal . | LOL . |
| 240 (46) | 132 (25) | 149 (29) | 90 (51) | 49 (28) | 36 (21) | 94 (42) | 82 (37) | 46 (21) | ||
| . | . | Chance of cure, n (%) . | Chance of cure, n (%) . | Chance of cure, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | . | Good (>75%) . | Maybe (25%-74%) . | Poor (<25%) . | Good (>75%) . | Maybe (25%-74%) . | Poor (<25%) . | Good (>75%) . | Maybe (25%-74%) . | Poor (<25%) . |
| Patient perception | 338 (65) | 162 (31) | 22 (4) | 110 (60) | 63 (35) | 10 (6) | 140 (61) | 87 (38) | 1 (<1) | |
| Physician perception | 36 (7) | 309 (64) | 137 (28) | 14 (7) | 90 (47) | 89 (46) | 13 (6) | 179 (78) | 34 (15) | |
| . | . | Chance of cure, n (%) . | Chance of cure, n (%) . | Chance of cure, n (%) . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| . | . | Good (>75%) . | Maybe (25%-74%) . | Poor (<25%) . | Good (>75%) . | Maybe (25%-74%) . | Poor (<25%) . | Good (>75%) . | Maybe (25%-74%) . | Poor (<25%) . |
| Patient perception | 338 (65) | 162 (31) | 22 (4) | 110 (60) | 63 (35) | 10 (6) | 140 (61) | 87 (38) | 1 (<1) | |
| Physician perception | 36 (7) | 309 (64) | 137 (28) | 14 (7) | 90 (47) | 89 (46) | 13 (6) | 179 (78) | 34 (15) | |
LOL, length of life.
Data selected from either 3- or 6-month follow-up assessment per patient, whichever had earliest responses.